Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

Braxia Scientific Reports Q3 2024 Financial Results

Newsfile February 29, 2024

Braxia Scientific Reports Mandatory Conversion of Debentures

Newsfile January 15, 2024

Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update

Newsfile November 30, 2023

Braxia Scientific Reports Q1 Fiscal 2024 Financial Results

Newsfile August 30, 2023

Braxia Scientific Reports Fiscal 2023 Financial Results

Newsfile July 31, 2023

RETRANSMISSION: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Newsfile June 12, 2023

Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Newsfile June 9, 2023

Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP

Newsfile March 16, 2023

Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

Newsfile March 1, 2023

Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement

Newsfile February 27, 2023

REPEAT - Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics

GlobeNewswire February 21, 2023

Braxia Scientific (CSE:BRAX) announces $1.9M financing transactions

Caroline Egan  February 7, 2023

Braxia Scientific Announces Offering up to $1.5 Million, Braxia Management to Participate in Concurrent Private Placement

Newsfile February 7, 2023

RETRANSMISSION: Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

Newsfile January 30, 2023

Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

GlobeNewswire January 30, 2023

Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

GlobeNewswire January 27, 2023

Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.

Newsfile January 10, 2023

Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US

GlobeNewswire January 10, 2023

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America

PR Newswire November 29, 2022

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders

PR Newswire November 1, 2022